)按病因分为非酒精性脂肪性肝炎(Nonalcoholic steatohepatitis,NASH)和酒精性肝炎(Alcoholic hepatitis,AH)。脂肪性肝炎发病率随着人们生活水平的提高不断上升。酒精性肝炎治疗首先是禁酒,其次是保肝对症处理;而非
基于4个网页-相关网页
方法选择符合条件的72例非酒精性脂肪性肝炎患者，随机分为治疗组和对照组。
Methods 72 patients with nonalcoholic fatty liver diseases were randomly divided into two groups.
我们及其他研究者最近得出的这一结论适用于多种肝脏疾病，包括乙型慢性病毒性肝炎、丙型慢性病毒性肝炎、酒精性肝病和非酒精性脂肪肝。
We and others have pointed this out recently for several liver diseases, including chronic viral hepatitis B and c, alcoholic liver disease, and non-alcoholic fatty liver disease.
非酒精性脂肪性肝炎和其他脂肪性肝病的发病机制：四步模型，包括肝硬化进展的脂质释放和肝微梗阻的作用。
The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.
应用推荐